Fiji Declares National HIV Emergency as Meth Crisis Fuels Sharp Rise in Cases

In a sobering address on Tuesday, Fiji’s Health Minister Dr. Atonio Lalabalavu announced that the archipelago is officially in a state of HIV emergency. The declaration comes after a rapid climb in new diagnoses—2,016 in 2025 alone—signalling that the virus is no longer a peripheral problem but a national crisis.

What’s startling is the speed of the outbreak. Today, roughly one out of every 60 adults in Fiji tests positive for HIV, a stark reversal of the global trend where new infections have been falling for years. Even more troubling, only about 39 % of those living with the virus know it, and a mere 22 % are on antiretroviral therapy.

While sexual transmission still plays a role, the health ministry’s data point to a surge in injecting drug use as the chief driver. Fiji has become a key waypoint for methamphetamine shipments moving from the Americas toward markets in Australia, New Zealand and parts of Asia. The drug’s cheap, high‑potency stockpiles have seeped into local communities, sparking an addiction wave that often involves sharing needles.

In 2025, half of the newly identified HIV cases with a known transmission route were linked to people who inject drugs. The other half stemmed from unprotected sex—an outcome of low condom usage, multiple partners and a lingering stigma that discourages testing.

The ripple effects reach the most vulnerable. Save the Children Fiji reported that a two‑month‑old infant was recently diagnosed with both HIV and tuberculosis, making it the youngest known co‑infected patient in the country. Last year, 59 babies acquired HIV from their mothers, highlighting the urgent need for stronger prenatal screening and mother‑to‑child transmission prevention.

Stigma, however, remains a formidable barrier. Joeli Colati, who has lived with HIV for nearly two decades and leads the community group Fiji Network Plus, explains that fear of being recognised at clinics, cultural taboos around premarital sex, and a pervasive lack of accurate information keep many people away from testing and treatment.

In response, the government plans a multi‑pronged push: scaling up free testing sites, expanding access to antiretroviral drugs, rolling out pre‑exposure prophylaxis (PrEP), and—perhaps most controversially—a formal needle‑and‑syringe exchange program. “Do not wait until you feel unwell,” Lalabalavu urged, asking anyone who may have shared needles or had condom‑less sex to get tested immediately.

International partners, including UNAIDS, are watching closely. While global new infections fell by about 42 % between 2010 and 2025, Fiji’s numbers have risen sharply, and only 22 % of its infected population is on treatment compared with a worldwide average of 78 %.

The path ahead is uncertain, but the message is clear: without swift, coordinated action—and a shift in public attitudes—Fiji’s HIV epidemic could eclipse the health gains the nation has fought hard to achieve over the past decades.